Quizartinib specifically targets the FLT3-ITD mutant protein, blocking downstream MAPK/ERK, PI3K/AKT, and STAT5 signaling pathways, thereby inhibiting leukemia cell proliferation and inducing apoptosis.
Authentic
Guarantee
Fast Delivery
Privacy Copyright2024@ BIGBEAR All right reserved BIGBEAR



